Incyte Z Score
INCY   USA Stock  USD 66.73 1.72 2.65% 
Incyte Z Score  Incyte Z Score 
Incyte Z Score Analysis
Incyte Corp's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2018  2019  2020  2021 (projected)  
Receivables  307.6 M  308.81 M  481.99 M  520.05 M 
Inventories  6.97 M  11.4 M  16.43 M  17.72 M 
Z Score  =  Sum Of   5 Factors 
 
 
 
 

Incyte Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Incyte Corp is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Incyte Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incyte Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incyte Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
According to the company's disclosures, Incyte Corp has a Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The z score for all United States stocks is 100.0% higher than that of the company.
Incyte Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incyte Corp's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incyte Corp could also be used in its relative valuation, which is a method of valuing Incyte Corp by comparing valuation metrics of similar companies.Incyte Corp is currently under evaluation in z score category among related companies.
Incyte Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Incyte Corp from analyzing Incyte Corp's financial statements. These drivers represent accounts that assess Incyte Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incyte Corp's important valuation drivers and their relationship over time.
2016  2017  2018  2019  2020  2021 (projected)  
Net Income Per Employee  106.06 K  (259.22 K)  80.1 K  306.94 K  (166.32 K)  (170.7 K)  
Revenue Per Employee  1.13 M  1.27 M  1.38 M  1.48 M  1.5 M  1.21 M  
Average Assets  1.43 B  1.98 B  2.47 B  3.09 B  3.21 B  3.46 B  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  155.94 M  (298.29 M)  149.19 M  520.75 M  (157.64 M)  (161.79 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  204.57 M  (253.21 M)  171.86 M  543.18 M  (178.24 M)  (182.93 M)  
Earnings before Tax  107.4 M  (312.29 M)  115.35 M  486.79 M  (232.22 M)  (238.33 M)  
Average Equity  328.57 M  1.35 B  1.77 B  2.34 B  2.32 B  2.5 B  
Enterprise Value  18.95 B  18.88 B  12.44 B  17.16 B  17.59 B  16.21 B  
Free Cash Flow  184.48 M  (204.01 M)  262.74 M  632.59 M  (311.98 M)  (320.19 M)  
Invested Capital  949.32 M  658.26 M  701.98 M  781.16 M  1.12 B  977.06 M  
Invested Capital Average  924.01 M  574.03 M  685.94 M  780.37 M  996.57 M  879.01 M  
Market Capitalization  18.89 B  19.99 B  13.53 B  18.81 B  19.05 B  17.24 B  
Tangible Asset Value  1.22 B  1.91 B  2.27 B  3.08 B  3.23 B  3.49 B  
Working Capital  720.68 M  1.13 B  1.41 B  1.97 B  1.73 B  1.4 B 
Incyte Fundamentals
Return On Equity  12.79 %  
Return On Asset  7.54 %  
Profit Margin  12.41 %  
Operating Margin  17.83 %  
Current Valuation  15.11 B  
Shares Outstanding  219.92 M  
Shares Owned by Insiders  1.46 %  
Shares Owned by Institutions  93.85 %  
Number of Shares Shorted  5.86 M  
Price to Earning  29.78 X  
Price to Book  5.24 X  
Price to Sales  5.25 X  
Revenue  2.72 B  
Gross Profit  276.63 M  
EBITDA  485.19 M  
Net Income  337.64 M  
Cash and Equivalents  2.08 B  
Cash per Share  9.45 X  
Total Debt  34.25 M  
Debt to Equity  0.011 %  
Current Ratio  3.96 X  
Book Value Per Share  12.41 X  
Cash Flow from Operations  764.91 M  
Short Ratio  4.63 X  
Earnings Per Share  2.18 X  
Price to Earnings To Growth  1.21 X  
Number of Employees  1.77 K  
Beta  0.8  
Market Capitalization  14.29 B  
Total Asset  1.01 B  
Retained Earnings  (1.54 B)  
Working Capital  674.37 M  
Current Asset  842.38 M  
Current Liabilities  168.01 M 
About Incyte Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incyte Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incyte Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incyte Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1773 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Incyte Corp without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal 
All Next  Launch Module 
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Incyte Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Please see Incyte Corp Piotroski F Score and Incyte Corp Valuation analysis. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Incyte Stock analysis
When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world  Go  
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities  Go  
Efficient FrontierPlot and analyze your portfolio and positions against riskreturn landscape of the market.  Go  
Money ManagersScreen money managers from public funds and ETFs managed around the world  Go  
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk  Go  
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities  Go 
The market value of Incyte Corp is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte Corp's value that differs from its market value or its book value, called intrinsic value, which is Incyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte Corp's market value can be influenced by many factors that don't directly affect Incyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.